Publicaciones en las que colabora con RAFAEL BAÑARES CAÑIZARES (67)

2023

  1. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma

    JHEP Reports, Vol. 5, Núm. 3

  2. Implementation and impact of an antibiotic control program and multidrug-resistant bacterial colonization in a liver transplant unit

    Revista Espanola de Enfermedades Digestivas, Vol. 115, Núm. 7, pp. 357-361

2022

  1. Decreased Long-Term Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Immunity in Liver Transplantation Recipients 12 Months After Coronavirus Disease 2019

    Liver Transplantation, Vol. 28, Núm. 6, pp. 1039-1050

  2. Liver and spleen volumes are associated with prognosis of compensated and decompensated cirrhosis and parallel its natural history

    United European Gastroenterology Journal, Vol. 10, Núm. 8, pp. 805-816

  3. Sinusoidal obstruction syndrome after liver transplantation: A multicenter observational study

    Liver Transplantation, Vol. 28, Núm. 7, pp. 1257-1261

2021

  1. HCV eradication in recurrent hepatitis C after liver transplantation normalizes enhanced endothelial activation

    Transplant International, Vol. 34, Núm. 11, pp. 2214-2225

  2. Long-term outcomes and clinical impact of anti-HLA donor-specific antibodies (DSA) after liver transplantation: a prospective study in a pilot cohort

    Revista Española de Enfermedades Digestivas, Vol. 113, Núm. 8, pp. 557-562

  3. Tacrolimus as an Effective and Durable Second-Line Treatment for Chronic Autoimmune Hepatitis: A Multicentric Study

    Digestive Diseases and Sciences, Vol. 66, Núm. 8, pp. 2826-2832

2020

  1. Intraoperative Troponin Elevation in Liver Transplantation Is Independently Associated With Mortality: A Prospective Observational Study

    Liver Transplantation, Vol. 26, Núm. 5, pp. 681-692

2019

  1. Clinical Utility of a Risk-Adapted Protocol for the Evaluation of Coronary Artery Disease in Liver Transplant Recipients

    Liver Transplantation, Vol. 25, Núm. 8, pp. 1177-1186

2018

  1. Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

    American Journal of Transplantation, Vol. 18, Núm. 10, pp. 2513-2522

  2. Fungaemia caused by rare yeasts: Incidence, clinical characteristics and outcome over 10 years

    Journal of Antimicrobial Chemotherapy

2017

  1. De novo autoimmune hepatitis after liver transplantation: A focus on glutathione S-transferase theta 1

    Liver Transplantation, Vol. 23, Núm. 1, pp. 75-85

  2. Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort study

    Transplant International, Vol. 30, Núm. 10, pp. 1041-1050

2016

  1. Early measurement of indocyanine green clearance accurately predicts short-term outcomes after liver transplantation

    Transplantation, Vol. 100, Núm. 3, pp. 613-620

  2. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  3. Liver Support With Albumin Dialysis Reduces Hepatitis C Virus Viremia and Facilitates Antiviral Treatment of Severe Hepatitis C Virus Recurrence After Liver Transplantation

    Therapeutic Apheresis and Dialysis, Vol. 20, Núm. 2, pp. 189-196

  4. Manifestaciones extradigestivas de la cirrosis

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 12, Núm. 11, pp. 627-634

  5. The current treatment landscape: The need for antifungal stewardship programmes

    Journal of Antimicrobial Chemotherapy, Vol. 71, pp. ii5-ii12

2015

  1. V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante

    Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637